MYGN
Myriad Genetics Inc
4.50$
+11.8%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | -73.1% | +842.9% | -347.0% | – | – | -49.8% | -248.1% | – | – | |
| – | +7.1% | +4.0% | -3.2% | +0.7% | -3.3% | -2.7% | -2.1% | -10.6% | +0.0% | +0.0% | +0.0% | – | |
| – | -10.3% | +15.4% | +20.8% | -14.5% | -12.1% | -12.8% | +12.6% | +14.0% | -77.0% | +132.1% | +10.8% | – | |
| – | – | – | – | – | – | – | – | – | -107.5% | – | – | – | |
| – | -22.9% | -36.3% | -39.5% | -32.7% | +68.6% | -10.2% | +30.2% | -59.4% | +114.3% | -10.0% | -61.1% | – | |
| – | +380.0% | -40.8% | -9.9% | – | -178.7% | +40.7% | -16.9% | -10.1% | -3.2% | +8.3% | -50.8% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | +4,750.0% | -100.5% | – | -99.8% | -200.0% | +100.0% | – | |
| – | – | -107.2% | – | -229.2% | – | +547.6% | -80.9% | +2,061.5% | -114.6% | -63.4% | – | – | |
| – | – | -163.1% | – | – | -72.0% | -619.0% | – | – | -104.9% | – | – | – | |
| – | – | – | – | – | – | -3,185.7% | – | – | -74.9% | -558.7% | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.